Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Geldenhuys

Showing results (51-60 of 174) with videos related to

Pageof 18
Sort By:
Therapeutic Delivery|August 26, 2015
Molecular determinants of blood-brain barrier permeationWerner J Geldenhuys, Afroz S Mohammad, Chris E Adkins, et al.
Scientific Reports|September 15, 2022
Interphotoreceptor matrix proteoglycans IMPG1 and IMPG2 proteolyze in the SEA domain and reveal localization mutual dependencyBenjamin Mitchell, Chloe Coulter, Werner J Geldenhuys, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2024
Synthesis and evaluation of enzyme inhibition by novel TT01001 derivatives as monoamine oxidase B inhibitorsMatheus Barbosa Belchior, Riley T Kane, Jason D Huber, et al.
Chemical Research in Toxicology|May 24, 2019
4-Hydroxynonenal and 4-Oxononenal Differentially Bind to the Redox Sensor MitoNEETDayna Arnett, Alexandria Quillin, Werner J Geldenhuys, et al.
Journal of Neurochemistry|October 24, 2006
Multifunctional drugs with different CNS targets for neuropsychiatric disordersCornelis J Van der Schyf, Werner J Geldenhuys, Moussa B H Youdim
Journal of Neurochemistry|August 21, 2010
Chronic exposure to nicotine and saquinavir decreases endothelial Notch-4 expression and disrupts blood-brain barrier integrityVamshi K Manda, Rajendar K Mittapalli, Werner J Geldenhuys, et al.
Parkinsonism & Related Disorders|November 19, 2008
Why should we use multifunctional neuroprotective and neurorestorative drugs for Parkinson's disease?Moussa B H Youdim, Werner J Geldenhuys, Cornelis J Van der Schyf
Expert Opinion on Therapeutic Patents|June 26, 2014
Parkinson's disease biomarker: a patent evaluation of WO2013153386Werner J Geldenhuys, Samir M Abdelmagid, Patrick J Gallegos, et al.
Neurochemical Research|January 28, 2005
Cation transport specificity at the blood-brain barrierPaul R Lockman, James H McAfee, Werner J Geldenhuys, et al.
Advances in Redox Research|October 4, 2024
Biochemical Control of the Mitochondrial Protein MitoNEET by Biological Thiols and Lipid-derived ElectrophilesR A Skolik, W J Geldenhuys, M E Konkle, et al.
Pageof 18

Showing results (51-60 of 174) with videos related to

Sort By:
Pageof 18
Therapeutic Delivery|August 26, 2015
Molecular determinants of blood-brain barrier permeationWerner J Geldenhuys, Afroz S Mohammad, Chris E Adkins, et al.
Scientific Reports|September 15, 2022
Interphotoreceptor matrix proteoglycans IMPG1 and IMPG2 proteolyze in the SEA domain and reveal localization mutual dependencyBenjamin Mitchell, Chloe Coulter, Werner J Geldenhuys, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2024
Synthesis and evaluation of enzyme inhibition by novel TT01001 derivatives as monoamine oxidase B inhibitorsMatheus Barbosa Belchior, Riley T Kane, Jason D Huber, et al.
Chemical Research in Toxicology|May 24, 2019
4-Hydroxynonenal and 4-Oxononenal Differentially Bind to the Redox Sensor MitoNEETDayna Arnett, Alexandria Quillin, Werner J Geldenhuys, et al.
Journal of Neurochemistry|October 24, 2006
Multifunctional drugs with different CNS targets for neuropsychiatric disordersCornelis J Van der Schyf, Werner J Geldenhuys, Moussa B H Youdim
Journal of Neurochemistry|August 21, 2010
Chronic exposure to nicotine and saquinavir decreases endothelial Notch-4 expression and disrupts blood-brain barrier integrityVamshi K Manda, Rajendar K Mittapalli, Werner J Geldenhuys, et al.
Parkinsonism & Related Disorders|November 19, 2008
Why should we use multifunctional neuroprotective and neurorestorative drugs for Parkinson's disease?Moussa B H Youdim, Werner J Geldenhuys, Cornelis J Van der Schyf
Expert Opinion on Therapeutic Patents|June 26, 2014
Parkinson's disease biomarker: a patent evaluation of WO2013153386Werner J Geldenhuys, Samir M Abdelmagid, Patrick J Gallegos, et al.
Neurochemical Research|January 28, 2005
Cation transport specificity at the blood-brain barrierPaul R Lockman, James H McAfee, Werner J Geldenhuys, et al.
Advances in Redox Research|October 4, 2024
Biochemical Control of the Mitochondrial Protein MitoNEET by Biological Thiols and Lipid-derived ElectrophilesR A Skolik, W J Geldenhuys, M E Konkle, et al.
Pageof 18